Thalis Asimakopoulos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thalis Asimakopoulos has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Athanasia Tsaroucha
1st Department of Anesthesiology and Pain Medicine, Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, Greece
3 shared publicationsGiustino Varrassi
Fondazione Paolo Procacci, Rome, Italy
2 shared publicationsMartina Rekatsina
1st Department of Anesthesiology and Pain Medicine, Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, Greece
2 shared publications- Martina Rekatsina
1st Anaesthesiology Department, Aretaieion University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece
2 shared publications Aikaterini Melemeni
Natl & Kapodistrian Univ Athens, Aretaie Univ Hosp, Dept Anesthesiol 1, Athens, Greece
1 shared publicationAlberto Pasqualucci
Department of Anesthesia and Pain Medicine, University of Perugia, Perugia, Italy
1 shared publication
Latest Publications
- Open Access
- 11 August 2026
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 27 (1) , 204
Pain in Parkinson’s disease: bridging pathophysiology, clinical features, and personalized management
- 11 August 2026
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 27 (1) , 204
Open AccessPain in Parkinson’s disease: bridging pathophysiology, clinical features, and personalized management
- Open Access
- 17 June 2026
- Published by Springer Nature in Pain and Therapy
- Vol. 15 (4) , 1049-1064
Transcutaneous Pulsed Radiofrequency in Chronic Pain: A Systematic Review of Randomized Controlled Trials
Transcutaneous pulsed radiofrequency (TcPRF) is a non-invasive neuromodulation technique increasingly investigated for the management of chronic pain. However, its clinical efficacy and safety across different chronic pain conditions remains uncertain. A systematic search of PubMed, Scopus, and Google Scholar was performed from database inception to March 2026. Randomized controlled trials (RCTs) evaluating TcPRF in chronic pain conditions were included. Pain intensity, functional outcomes, and safety data were extracted. Risk of bias was assessed using the Cochrane RoB 2 tool. Eight RCTs were included, encompassing both musculoskeletal and neuropathic pain conditions. TcPRF was associated with reductions in pain intensity in most studies, with more consistent effects observed in sham-controlled trials and at later follow-up time points. Functional outcomes generally improved in parallel with pain, although results varied depending on the outcome measures used. TcPRF was well tolerated, with no serious adverse events reported. However, substantial heterogeneity was noted in patient populations, comparator interventions, treatment protocols, and outcome measures. TcPRF appears to be a promising non-invasive treatment option for selected chronic pain conditions, particularly when a minimally invasive approach is preferred. Nevertheless, current evidence remains limited by heterogeneity and methodological variability. Further large-scale, well-designed RCTs with standardized treatment protocols and longer follow-up are required to clarify its clinical role.
- 17 June 2026
- Published by Springer Nature in Pain and Therapy
- Vol. 15 (4) , 1049-1064
Open AccessTranscutaneous Pulsed Radiofrequency in Chronic Pain: A Systematic Review of Randomized Controlled Trials
Transcutaneous pulsed radiofrequency (TcPRF) is a non-invasive neuromodulation technique increasingly investigated for the management of chronic pain. However, its clinical efficacy and safety across different chronic pain conditions remains uncertain. A systematic search of PubMed, Scopus, and Google Scholar was performed from database inception to March 2026. Randomized controlled trials (RCTs) evaluating TcPRF in chronic pain conditions were included. Pain intensity, functional outcomes, and safety data were extracted. Risk of bias was assessed using the Cochrane RoB 2 tool. Eight RCTs were included, encompassing both musculoskeletal and neuropathic pain conditions. TcPRF was associated with reductions in pain intensity in most studies, with more consistent effects observed in sham-controlled trials and at later follow-up time points. Functional outcomes generally improved in parallel with pain, although results varied depending on the outcome measures used. TcPRF was well tolerated, with no serious adverse events reported. However, substantial heterogeneity was noted in patient populations, comparator interventions, treatment protocols, and outcome measures. TcPRF appears to be a promising non-invasive treatment option for selected chronic pain conditions, particularly when a minimally invasive approach is preferred. Nevertheless, current evidence remains limited by heterogeneity and methodological variability. Further large-scale, well-designed RCTs with standardized treatment protocols and longer follow-up are required to clarify its clinical role.
- Open Access
- 15 March 2025
- Published by Springer Nature in Pain and Therapy
- Vol. 14 (3) , 775-789
The Role of Biomarkers in Acute Pain: A Narrative Review
Acute pain, a critical aspect of patient care, presents a challenge due to its subjective nature and complex biological underpinnings. Biomarkers for acute pain promise a paradigm shift in how pain is perceived, diagnosed, and managed. The study of genetic, inflammatory, and neurotransmission markers associated with pain experience may hold the key for the development of personalized and effective pain management strategies. This narrative review explores the neurobiological pathways of acute pain, encompassing inflammatory responses and neurotransmission mechanisms. It synthesizes current research on the identification and clinical application of biomarkers, emphasizing their potential to enhance diagnostic precision, treatment effectiveness, and risk prediction. We underscore the promising role of acute pain biomarkers in identifying patients at risk for developing acute and potentially chronic pain, predicting patients’ response to pharmacological interventions, and aiding in the development of novel therapeutic and pain preventive strategies. The evolving landscape of biomarker research not only deepens our understanding of pain mechanisms but also lays the foundation for more tailored and patient-specific healthcare interventions.
- 15 March 2025
- Published by Springer Nature in Pain and Therapy
- Vol. 14 (3) , 775-789
Open AccessThe Role of Biomarkers in Acute Pain: A Narrative Review
Acute pain, a critical aspect of patient care, presents a challenge due to its subjective nature and complex biological underpinnings. Biomarkers for acute pain promise a paradigm shift in how pain is perceived, diagnosed, and managed. The study of genetic, inflammatory, and neurotransmission markers associated with pain experience may hold the key for the development of personalized and effective pain management strategies. This narrative review explores the neurobiological pathways of acute pain, encompassing inflammatory responses and neurotransmission mechanisms. It synthesizes current research on the identification and clinical application of biomarkers, emphasizing their potential to enhance diagnostic precision, treatment effectiveness, and risk prediction. We underscore the promising role of acute pain biomarkers in identifying patients at risk for developing acute and potentially chronic pain, predicting patients’ response to pharmacological interventions, and aiding in the development of novel therapeutic and pain preventive strategies. The evolving landscape of biomarker research not only deepens our understanding of pain mechanisms but also lays the foundation for more tailored and patient-specific healthcare interventions.
- Open Access
- 18 March 2024
- Published by PAGEPress Publications in Advancements in Health Research
- Vol. 1 (1)
Piezo channels in migraine and trigeminal pain syndromes: a systematic review of their role in pain pathways
Piezo channels, a class of mechanosensitive ion channels, have emerged as key players in sensory transduction. Piezo1 and Piezo2 have been implicated in various physiological processes, including touch sensation and nociception. Their association with migraine and their role in pain involving trigeminal nerve have gained significant research attention. Following PRISMA guidelines, we performed a systematic review of the literature, on the role of Piezo1 and Piezo2 channels in migraine and trigeminal pain. From PubMed, Cochrane Library, and Scopus, we deemed 20 studies published between 2014 and 2023 appropriate to be included in this review. Piezo1 emerges as a key player in migraine pathogenesis, contributing to meningeal nociception and pain generation. In trigeminal pain syndromes, Piezo channels, particularly Piezo2, have a role in various pain conditions, from corneal nociception to dental and orofacial pain. Mechanistic insights provide potential therapeutic targets for migraine and other pain conditions involving trigeminal nerve. This systematic review accentuates the emerging significance of Piezo channels in migraine and trigeminal-associated pain, underscoring cross-associations that interconnect Piezo channels, migraine, and trigeminal neurons, as well as suggesting promising avenues for targeted therapeutic interventions and future research directions.
- 18 March 2024
- Published by PAGEPress Publications in Advancements in Health Research
- Vol. 1 (1)
Open AccessPiezo channels in migraine and trigeminal pain syndromes: a systematic review of their role in pain pathways
Piezo channels, a class of mechanosensitive ion channels, have emerged as key players in sensory transduction. Piezo1 and Piezo2 have been implicated in various physiological processes, including touch sensation and nociception. Their association with migraine and their role in pain involving trigeminal nerve have gained significant research attention. Following PRISMA guidelines, we performed a systematic review of the literature, on the role of Piezo1 and Piezo2 channels in migraine and trigeminal pain. From PubMed, Cochrane Library, and Scopus, we deemed 20 studies published between 2014 and 2023 appropriate to be included in this review. Piezo1 emerges as a key player in migraine pathogenesis, contributing to meningeal nociception and pain generation. In trigeminal pain syndromes, Piezo channels, particularly Piezo2, have a role in various pain conditions, from corneal nociception to dental and orofacial pain. Mechanistic insights provide potential therapeutic targets for migraine and other pain conditions involving trigeminal nerve. This systematic review accentuates the emerging significance of Piezo channels in migraine and trigeminal-associated pain, underscoring cross-associations that interconnect Piezo channels, migraine, and trigeminal neurons, as well as suggesting promising avenues for targeted therapeutic interventions and future research directions.
- Open Access
- 26 February 2024
- Published by Springer Nature in Cureus
- Vol. 16 (2) , e54966
Epidural Anesthesia for Neuromyelitis Optica in Obstetrics: A Case Report and Literature Review
Neuromyelitis optica (NMO), also known as Devic disease, poses unique challenges in obstetrical anesthesia, with limited research available. This case report presents the anesthetic management of a 43-year-old gravida 2 para 1 (G2P1) woman with NMO undergoing labor induction at 39 weeks of gestation. Having received uneventful epidural labor analgesia in her first pregnancy, she faced the delicate decision of neuraxial anesthesia in light of her NMO diagnosis, which was made following her initial pregnancy. Collaborative discussions resulted in the choice of labor epidural analgesia, and an indwelling epidural catheter was placed successfully. An unplanned cesarean section with effective epidural supplementation followed. The case highlights the intricacies of balancing pain relief and neurological risks in NMO patients. Existing literature reflects varying perspectives on neuraxial anesthesia in NMO, with reports both supporting and cautioning against its use. The case aligns with the current view that epidural labor analgesia appears safe in NMO, but conclusive recommendations await larger studies. The decision for neuraxial anesthesia in NMO should be individualized, guided by comprehensive pre-anesthetic counseling and ongoing research developments.
- 26 February 2024
- Published by Springer Nature in Cureus
- Vol. 16 (2) , e54966
Open AccessEpidural Anesthesia for Neuromyelitis Optica in Obstetrics: A Case Report and Literature Review
Neuromyelitis optica (NMO), also known as Devic disease, poses unique challenges in obstetrical anesthesia, with limited research available. This case report presents the anesthetic management of a 43-year-old gravida 2 para 1 (G2P1) woman with NMO undergoing labor induction at 39 weeks of gestation. Having received uneventful epidural labor analgesia in her first pregnancy, she faced the delicate decision of neuraxial anesthesia in light of her NMO diagnosis, which was made following her initial pregnancy. Collaborative discussions resulted in the choice of labor epidural analgesia, and an indwelling epidural catheter was placed successfully. An unplanned cesarean section with effective epidural supplementation followed. The case highlights the intricacies of balancing pain relief and neurological risks in NMO patients. Existing literature reflects varying perspectives on neuraxial anesthesia in NMO, with reports both supporting and cautioning against its use. The case aligns with the current view that epidural labor analgesia appears safe in NMO, but conclusive recommendations await larger studies. The decision for neuraxial anesthesia in NMO should be individualized, guided by comprehensive pre-anesthetic counseling and ongoing research developments.
- Open Access
- 20 August 2023
- Published by Springer Nature in Cureus
- Vol. 15 (8) , e43805
The Efficacy of Stellate Ganglion Blockade in Herpetic Neuralgia: A Case Report
The varicella-zoster virus can reactivate in patients with impaired cell-mediated immunity, resulting in herpes zoster (HZ) and sometimes in herpetic neuralgia (HN). Stellate ganglion blockade (SGB) has been studied for the treatment of HN and postherpetic neuralgia (PHN), but its effectiveness in preventing PHN in patients with acute HZ is not well-established. Here, we present a case of a 75-year-old woman who underwent SGB for HN of the right upper limb. The patient had been treated with antivirals and various analgesics, but adverse effects due to analgesics led to discontinuation of them. After the first application of SGB, the patient experienced significant pain reduction, and after a second application, complete remission of pain was achieved. Nine months later, the patient remained symptom-free and without PHN. The therapeutic potential of SGB in the treatment of HN and its role in preventing PHN requires further investigation.
- 20 August 2023
- Published by Springer Nature in Cureus
- Vol. 15 (8) , e43805
Open AccessThe Efficacy of Stellate Ganglion Blockade in Herpetic Neuralgia: A Case Report
The varicella-zoster virus can reactivate in patients with impaired cell-mediated immunity, resulting in herpes zoster (HZ) and sometimes in herpetic neuralgia (HN). Stellate ganglion blockade (SGB) has been studied for the treatment of HN and postherpetic neuralgia (PHN), but its effectiveness in preventing PHN in patients with acute HZ is not well-established. Here, we present a case of a 75-year-old woman who underwent SGB for HN of the right upper limb. The patient had been treated with antivirals and various analgesics, but adverse effects due to analgesics led to discontinuation of them. After the first application of SGB, the patient experienced significant pain reduction, and after a second application, complete remission of pain was achieved. Nine months later, the patient remained symptom-free and without PHN. The therapeutic potential of SGB in the treatment of HN and its role in preventing PHN requires further investigation.